Skip to main content
Fig. 9 | BMC Pulmonary Medicine

Fig. 9

From: A comprehensive comparison of the safety and efficacy of drugs in the treatment of idiopathic pulmonary fibrosis: a network meta-analysis based on randomized controlled trials

Fig. 9

Network evidence map of the proportion of patients with decline in FVC≥10% predicted. A total of 10 studies reported the effect of the proportion of patients with decline in FVC≥ 10% predicted of 5 drugs: 1 of Ambrisentan, 4 of Nintedanib, 1 of Pamrevlumab, 3 of Pirfenidone, 1 of Warfarin

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us